Inhaled migraine med passes early safety check in healthy volunteers
NCT ID NCT00610727
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single inhaled dose of prochlorperazine in 54 healthy adults to see if it is safe and how the body processes it. The goal was to gather information for future migraine treatments. No treatment benefit was measured, as participants were healthy volunteers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Phase I Clinic
Austin, Texas, 78704-7016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Experimental migraine drug JS010 takes first step in human safety trial
- Scientists probe shared pain pathways in endometriosis and migraine
- Brain scans and heat tests may predict migraine in teens
- Could a simple diary ease the burden of migraine?